RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $1.7M of Royalty Pharma plc
Sold$1,659,489
$39.92Price
41,575Shares
−15%Stake
What RPRX did after the filing
- The stock from Thu, Dec 4 open, $39.12
- −1.0%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 20 close.
Traded Mon, Dec 1. Filed Wed, Dec 3, 5:10 PM ET, after the close. Returns use the Dec 4 open and the Jan 20 close. Not investment advice.